Skip to Menu Skip to Search Contact Us Skip to Content
US Flag

You are accessing SGS’s website from the USA.

Visit the US website instead

Stay on the global website and remember my choice


Clinical, regulatory and biosafety experts explore challenges and strategies in vaccine development, demonstrating how to expedite the development of cost-effective vaccines.


September 9, 2014


September 16, 2014



Whether you are a health authorities or vaccine manufacturers, you need to find more efficacious, cost-effective vaccines while expediting vaccine development to serve larger populations and meet potential pandemic threats. Plus, you must navigate a variety of regulatory, biosafety, and clinical development challenges to meet these demands.

This webcast will explore a range of regulatory, biosafety, and clinical strategies for anyone involved in vaccine development. It will also address vital strategies for the development of seasonal and pandemic influenza vaccines, as well as universal vaccines.

Webinar Summary

The webcast will include:

  • A clinical expert’s review, exploring how viral challenge testing can optimize the development of both traditional and emerging types of vaccines
  • A case study showing how a vaccine clinical development, plan using viral challenge testing, can demonstrate vaccine efficacy earlier in the development process and a faster, more efficient path compared to traditional methods
  • A biosafety expert’s review of viral biosafety testing strategies, including the different approaches for traditional egg-based vaccines. The review will also cover novel technologies, such as cell culture-based vaccines, testing viral vaccine cell substrates, and seed stock characterization methods
  • A regulatory expert’s perspective on new and evolving vaccine approval trends and challenges among health authorities worldwide

Key Learning Objectives

This webinar will help you:

  • Understand regulatory challenges in developing vaccines in a global marketplace
  • Review biosafety test methods for various vaccine platforms
  • Learn how viral challenge testing can demonstrate efficacy earlier in the development process

Who Should Attend?

This webinar is particularly aimed at:

  • Vaccine research and development leaders
  • Clinical trials designers and managers
  • Clinical research development team members
  • QA/QC directors and managers
  • Laboratory analysts
  • Regulatory affairs
  • Directors and managers involved in vaccine manufacturing

Expert Speakers

Expert speakers include:

  • Robert Lins, MD, PhD, Senior Clinical Advisor, Clinical Research, SGS Life Science Services
  • Archie Lovatt, PhD, Scientific Operations Director, SGS Vitrology

Dates and Times

September 9, 2014, 11 am Eastern US
September  16, 2014, 15:00 Central European Time

For more information please contact:

Ferdinand Dabu
75 Passaic Avenue
Fairfield NJ 07004 US
t: +1 888 747 8782